EAS Consulting Group
Regulatory consulting firm offering label and claims review, NDI notifications and training programs.
- ENGAGEMENT
- Project-based (consulting)
- LEAD TIME
- Not publicly disclosed
Overview
EAS Consulting Group is one of the largest FDA regulatory consulting firms in the United States, with a network of over 200 independent consultants specializing in dietary supplement, food, drug, medical device, and cosmetic compliance. A Certified Group company, EAS provides comprehensive consulting, training, and auditing services for DSHEA compliance, 21 CFR Part 111 GMP requirements, label and claims review, New Dietary Ingredient (NDI) notifications, and FDA inspection preparation. Their consultant network includes former FDA investigators and industry quality experts who conduct GMP audits, mock inspections, and gap analyses.
Certifications
0 of 1 certification independently confirmed. What this means
Capabilities
- PRODUCT TYPES
- GMP Consulting · Label & Claims Review · NDI Notifications · FDA Inspection Prep · Training Programs
- CAPABILITIES
- Claims review or substantiation · cGMP compliance or quality systems · GMP audits, mock inspections or training · FDA registration, US Agent or Prior Notice · Adverse event reporting
Sources
- EAS Consulting Group Official Website(2026-03-13)
- EAS Dietary Supplement Services(2026-03-13)
- EAS About Us(2026-03-13)
- EAS Supplement Training Programs(2026-03-13)
What we couldn't verify
We did not visit this company on site. See the limits that apply to every listing.
- Consulting firm, not a manufacturer; provides regulatory guidance only
- Network model (200+ independent consultants) means quality may vary by assigned consultant
- Specific consulting fees not publicly disclosed
Dietary supplement manufacturers must comply with 21 CFR Part 111 (cGMP). What Part 111 requires
The connection map between EAS Consulting Group and other vendors, capabilities, and certifications is in the manufacturer atlas.
Enforcement screening: included in Inventory Ready's most recent completed pass against FDA's published recall datasets (2026-07-09). Method and limits →
Our Evaluation Method
A full assessment applies six checks. Source-Checked listings get a lighter review.
- Independent confirmation: Claims backed by documentation, not marketing copy
- How recent the data is: Information reviewed and dated within the last 12 months
- Sources we traced: Sources cited for every key claim
- Inconsistencies flagged: Where a company's claims and public records disagree, we say so
- What we disclose: Material connections stated directly on affected listings
- What we don't know: When we can't assess something, we say so explicitly
Interested in EAS Consulting Group?
Tell us about your project and we'll help you determine if this regulatory consultant is a good fit.